| ★ | SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma | | 78 | Estados Unidos | |
| 19 | Treatment of NTM | National Jewish Health @nationaljewishhealth | 2.3K | Estados Unidos | 68 |
| 10 | Beyond Atherosclerosis: Coronary Calcium Scoring in Dyslipidemia, CKM Syndrome | | 2.0K | Estados Unidos | 70 |
| 2 | Upadacitinib Shows Strong Safety Profile in Severe Alopecia Areata | | 611 | Estados Unidos | 74 |
| 13 | Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B | | 521 | Estados Unidos | 69 |
| 18 | FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD | | 131 | Estados Unidos | 68 |
| 14 | Tezepelumab Reduced Severe Asthma Exacerbations Across Phenotypes | ATS 2026 | | 122 | Estados Unidos | 68 |
| 12 | Phase 3b ENCORE: ALIS Improves MAC Lung Disease Outcomes | ATS 2026 | | 117 | Estados Unidos | 69 |
| 4 | Obinutuzumab Achieves 95.5% Remission in INS, May Shift Steroid-Sparing Treatment Strategies | | 109 | Estados Unidos | 72 |
| 15 | How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD | | 109 | Estados Unidos | 68 |
| 1 | VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes | | 96 | Estados Unidos | 76 |
| 6 | Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD | | 88 | Estados Unidos | 71 |
| 11 | MAESTRO-NASH: Resmetirom May Reduce Cardiovascular Risk in MASH, With or Without Statins | | 86 | Estados Unidos | 70 |
| 17 | Dupilumab Doubled Asthma Remission Odds in Type 2 Asthma: | | 71 | Estados Unidos | 68 |
| 5 | Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients | ATS 2026 | | 68 | Estados Unidos | 72 |
| 9 | Omalizumab vs Oral Immunotherapy for Multifood Allergy | | 65 | Estados Unidos | 70 |
| 20 | Mifepristone Improves HbA1c, Weight in Poorly Controlled T2D, Regardless of GLP-1 Treatment | | 46 | Estados Unidos | 68 |
| 7 | Diagnosing Non-IgE Food Hypersensitivity | Brian Lacy, MD, PhD | EAC 2026 | | 31 | Estados Unidos | 71 |
| 16 | Key Non-Medication Clinical Pearls for Dermatologists, With Matthew Zirwas, MD | | 21 | Estados Unidos | 68 |
| 3 | Are You Misdiagnosing Atopic Dermatitis? Matthew Zirwas, MD, on Adult-Onset AD | | 19 | Estados Unidos | 73 |
| 8 | Patch Testing, Nickel, & IL-13 Inhibitors: Rethinking Eczematous Dermatitis Diagnosis | | 11 | Estados Unidos | 71 |